Sign in

CIK 0001082554

  • Large accelerated filer

UNITED THERAPEUTICS Corp

Sign in to watch
Ticker
UTHR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
521984749
Phone
+1 301-608-9292
Business address
1000 SPRING ST, SILVER SPRING, MD, 20910
  1. 4 Planned sale EVP & GENERAL COUNSEL sold 8,300 shares at an average $476.34 ($3,953,588)
  2. 4 Planned sale PRESIDENT AND COO sold 22,500 shares at $480.75 ($10,816,956)
  3. 4 Planned sale Director sold 50 shares at $474.68 ($23,734)
  4. 4 Planned sale PRESIDENT AND COO sold 22,500 shares at $474.65 ($10,679,686)
  5. 4 Planned sale EVP & GENERAL COUNSEL sold 8,300 shares at an average $483.25 ($4,010,940)
  6. 4 Planned sale Director sold 50 shares at $474.23 ($23,712)
  7. 4 Planned sale PRESIDENT AND COO sold 22,500 shares at $470.95 ($10,596,429)
  8. 4 Planned sale PRESIDENT AND COO sold 30,375 shares at an average $470.03 ($14,277,114)
  9. 4 Planned sale PRESIDENT AND COO sold 14,625 shares at an average $464.66 ($6,795,627)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Planned sale Director sold 50 shares at $460.98 ($23,049)
  13. 4 Planned sale EVP & GENERAL COUNSEL sold 8,300 shares at an average $469.89 ($3,900,122)
  14. 4 Planned sale PRESIDENT AND COO sold 22,500 shares at $479.51 ($10,788,876)
  15. 4 Planned sale PRESIDENT AND COO sold 14,625 shares at an average $487.38 ($7,127,877)
  16. 4 Planned sale PRESIDENT AND COO sold 7,875 shares at an average $487.38 ($3,838,085)
  17. 4 Planned sale Director sold 1,000 shares at $510.00 ($510,000)
  18. 4 Planned sale Director sold 50 shares at $495.01 ($24,751)
  19. 4 Planned sale Director sold 1,000 shares at $500.01 ($500,015)
  20. 4 Planned sale EVP & GENERAL COUNSEL sold 8,300 shares at an average $485.43 ($4,029,076)

Page 15 of 164 · 3,272 filings